{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:49:45Z","timestamp":1781534985543,"version":"3.54.5"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"publisher","award":["APVV-19-0189"],"award-info":[{"award-number":["APVV-19-0189"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018883","name":"Maurice Wilkins Centre for Molecular Biodiscovery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["19\/259"],"award-info":[{"award-number":["19\/259"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118324","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:07:42Z","timestamp":1761782862000},"page":"118324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Advancing the antituberculosis activity of nitropicolinic acids and amides"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2593-8559","authenticated-orcid":false,"given":"Andrew M.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yi","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley C.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Z\u00e1horszk\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Kordul\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Stelitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Recchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosalia","family":"Pasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojie","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahebraj","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan S.","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri S.","family":"Shetye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G.","family":"Franzblau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt L.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118324_bib1","series-title":"Political Declaration of the high-level Meeting of the General Assembly on the Fight Against Tuberculosis","year":"2023"},{"key":"10.1016\/j.ejmech.2025.118324_bib2","series-title":"Global Tuberculosis Report 2024","year":"2024"},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2025.118324_bib3","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ijid.2023.03.013","article-title":"Update of drug-resistant tuberculosis treatment guidelines: a turning point","volume":"130","author":"Vanino","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118324_bib4","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1021\/acs.jmedchem.2c00227","article-title":"Tuberculosis drug discovery: challenges and new horizons","volume":"65","author":"Fernandes","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib5","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1038\/s41467-023-39300-z","article-title":"DprE2 is a molecular target of the antitubercular nitroimidazole compounds pretomanid and delamanid","volume":"14","author":"Abrahams","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118324_bib6","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1021\/acsomega.7b00892","article-title":"In vitro evaluation of novel nitazoxanide derivatives against Mycobacterium tuberculosis","volume":"2","author":"Odingo","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118324_bib7","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1021\/jm9010719","article-title":"Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance","volume":"52","author":"de Carvalho","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01956-19","article-title":"Early bactericidal activity trial of nitazoxanide for pulmonary tuberculosis","volume":"64","author":"Walsh","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib9","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.1021\/jm050765n","article-title":"Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents","volume":"48","author":"Tangallapally","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib10","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/jac\/dkn307","article-title":"A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents","volume":"62","author":"Hurdle","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00474-23","article-title":"Discovery and characterization of antimycobacterial nitro-containing compounds with distinct mechanisms of action and in vivo efficacy","volume":"67","author":"Eke","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1515\/hc-2019-0007","article-title":"Synthesis and antitubercular activity of new N-[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]-(nitroheteroaryl)carboxamides","volume":"25","author":"Mart\u00ednez","year":"2019","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.ejmech.2025.118324_bib13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.chembiol.2015.05.016","article-title":"Thiophenecarboxamide derivatives activated by EthA kill Mycobacterium tuberculosis by inhibiting the CTP synthetase PyrG","volume":"22","author":"Mori","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118324_bib14","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1021\/acs.jmedchem.2c00972","article-title":"Nitroimidazopyrazinones with oral activity against tuberculosis and Chagas disease in mouse models of infection","volume":"65","author":"Ang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib15","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1021\/acs.jmedchem.8b01578","article-title":"Design, synthesis, and biological evaluation of 2-nitroimidazopyrazin-one\/-es with antitubercular and antiparasitic activity","volume":"61","author":"Jarrad","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000645","article-title":"High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors","volume":"5","author":"Christophe","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2025.118324_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1039\/c3md00366c","article-title":"Synthesis and biological evaluation of substituted N-alkylphenyl-3,5-dinitrobenzamide analogs as anti-TB agents","volume":"5","author":"Munagala","year":"2014","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.118324_bib18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/acsmedchemlett.8b00177","article-title":"Identification of N-benzyl 3,5-dinitrobenzamides derived from PBTZ169 as antitubercular agents","volume":"9","author":"Li","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118324_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cclet.2018.08.005","article-title":"Design, synthesis and antimycobacterial activity of novel nitrobenzamide derivatives","volume":"30","author":"Wang","year":"2019","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118324_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1021\/jm00211a027","article-title":"Studies on anticoccidial agents. 10. Synthesis and anticoccidial activity of 5-nitronicotinamide and its analogues","volume":"20","author":"Morisawa","year":"1977","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/jm00214a004","article-title":"Studies on anticoccidial agents. 11. Synthesis and anticoccidial activity of nitropyridinecarboxamides and derivatives","volume":"20","author":"Morisawa","year":"1977","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/jm00200a010","article-title":"Studies on anticoccidial agents. 12. Synthesis and anticoccidial activity of methyl-2(6)-nitro- and -3(5)-nitropyridinecarboxamides","volume":"21","author":"Morisawa","year":"1978","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00766-23","article-title":"Identification and optimization of pyridine carboxamide-based scaffold as a drug lead for Mycobacterium tuberculosis","volume":"68","author":"Singh","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115617","article-title":"Antimycobacterial pyridine carboxamides: from design to in vivo activity","volume":"258","author":"Nawrot","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib25","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1021\/jm501608q","article-title":"Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)","volume":"58","author":"Palmer","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib26","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1021\/acs.jmedchem.7b00034","article-title":"7-Substituted 2-nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: novel antitubercular agents lead to a new preclinical candidate for visceral leishmaniasis","volume":"60","author":"Thompson","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jconrel.2023.01.037","article-title":"\u03a0-\u03a0 interactions stabilize PeptoMicelle-based formulations of pretomanid derivatives leading to promising therapy against tuberculosis in zebrafish and mouse models","volume":"354","author":"Dal","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejmech.2025.118324_bib28","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1042\/BCJ20160186","article-title":"Exploring the structure of glutamate racemase from Mycobacterium tuberculosis as a template for anti-mycobacterial drug discovery","volume":"473","author":"Poen","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.118324_bib29","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1021\/jp201037t","article-title":"Nature of allosteric inhibition in glutamate racemase: discovery and characterization of a cryptic inhibitory pocket using atomistic MD simulations and pKa calculations","volume":"115","author":"Whalen","year":"2011","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2025.118324_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jinorgbio.2012.02.032","article-title":"Development of metal-chelating inhibitors for the class II fructose 1,6-bisphosphate (FBP) aldolase","volume":"112","author":"Labb\u00e9","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2025.118324_bib31","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1021\/jm5003606","article-title":"Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent","volume":"57","author":"Kang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ejmech.2016.09.082","article-title":"Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent","volume":"125","author":"Kang","year":"2017","journal-title":"Q203, Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31316-6","article-title":"Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1","volume":"8","author":"Richter","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118324_bib34","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1039\/b004270f","article-title":"The solid- and solution-state structures of 2-nitrosopyridine and its 3- and 4-methyl derivatives","volume":"2","author":"Gowenlock","year":"2000","journal-title":"J. Chem. Soc., Perkin Trans."},{"key":"10.1016\/j.ejmech.2025.118324_bib35","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1021\/ja311058q","article-title":"Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents","volume":"135","author":"Tiwari","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118324_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/07328309708006523","article-title":"A one-pot synthesis of glycosyl amides from glycosyl azides using a modified Staudinger reaction","volume":"16","author":"Maunier","year":"1997","journal-title":"J. Carbohydr. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bmcl.2018.12.053","article-title":"Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent","volume":"29","author":"Gallardo-Macias","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118324_bib38","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1021\/acs.jmedchem.8b00077","article-title":"Lipophilic efficiency as an important metric in drug design","volume":"61","author":"Johnson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib39","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118324_bib40","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2315069121","article-title":"Acceleration of infectious disease drug discovery and development using a humanized model of drug metabolism","volume":"121","author":"MacLeod","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.118324_bib41","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.102.039255","article-title":"Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs","volume":"303","author":"Mahar Doan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2025.118324_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03677-23","article-title":"The Mycobacterium tuberculosis MmpL3 inhibitor MSU-43085 is active in a mouse model of infection","volume":"12","author":"Williams","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2025.118324_bib43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00044-020-02676-4","article-title":"8-Cyanobenzothiazinone analogs with potent antitubercular activity","volume":"30","author":"Zhang","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.118324_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02204-18","article-title":"Rufomycin targets ClpC1 proteolysis in Mycobacterium tuberculosis and M. abscessus","volume":"63","author":"Choules","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib45","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1128\/AAC.00055-06","article-title":"Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis","volume":"51","author":"Cho","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib46","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/jac\/dkq374","article-title":"Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis","volume":"65","author":"de Steenwinkel","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00282-21","article-title":"In vitro profiling of antitubercular compounds by rapid, efficient, and nondestructive assays using autoluminescent Mycobacterium tuberculosis","volume":"65","author":"Shetye","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib48","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1056\/NEJMoa1201964","article-title":"Linezolid for treatment of chronic extensively drug-resistant tuberculosis","volume":"367","author":"Lee","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118324_bib49","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.1021\/acs.jmedchem.9b00912","article-title":"Development of 3,5-dinitrophenyl-containing 1,2,4-triazoles and their trifluoromethyl analogues as highly efficient antitubercular agents inhibiting decaprenylphosphoryl-\u03b2-D-ribofuranose 2\u2032-oxidase","volume":"62","author":"Karabanovich","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib50","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/AAC.39.11.2484","article-title":"Biogenesis of the mycobacterial cell wall and the site of action of ethambutol","volume":"39","author":"Mikusova","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib51","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3390\/app10072278","article-title":"Mycobacterial cell wall: a source of successful targets for old and new drugs","volume":"10","author":"Vilch\u00e8ze","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ejmech.2025.118324_bib52","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejmech.2016.07.028","article-title":"Pyrrolidinone and pyrrolidine derivatives: evaluation as inhibitors of InhA and Mycobacterium tuberculosis","volume":"123","author":"Matviiuk","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib53","doi-asserted-by":"crossref","first-page":"11241","DOI":"10.1073\/pnas.1901346116","article-title":"MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine","volume":"116","author":"Su","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.118324_bib54","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1021\/jm049972y","article-title":"Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents","volume":"47","author":"Tangallapally","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib55","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1080\/22221751.2021.2006578","article-title":"IMB-XMA0038, a new inhibitor targeting aspartate-semialdehyde dehydrogenase of Mycobacterium tuberculosis","volume":"10","author":"Wang","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ejmech.2025.118324_bib56","article-title":"Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis","volume":"169","author":"Batt","year":"2023","journal-title":"Microbiology (Read.)"},{"key":"10.1016\/j.ejmech.2025.118324_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/jb.00326-24","article-title":"Functions of nitroreductases in mycobacterial physiology and drug susceptibility","volume":"207","author":"Eke","year":"2025","journal-title":"J. Bacteriol."},{"issue":"Suppl A","key":"10.1016\/j.ejmech.2025.118324_bib58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/33.suppl_A.23","article-title":"Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens","volume":"33","author":"McOsker","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1021\/acs.jmedchem.3c00925","article-title":"Both nitro groups are essential for high antitubercular activity of 3,5-dinitrobenzylsulfanyl tetrazoles and 1,3,4-oxadiazoles through the deazaflavin-dependent nitroreductase activation pathway","volume":"67","author":"Karabanovich","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acsinfecdis.0c00622","article-title":"Design and synthesis of pyrano[3,2-b]indolones showing antimycobacterial activity","volume":"7","author":"Monakhova","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118324_bib61","doi-asserted-by":"crossref","first-page":"40659","DOI":"10.1021\/acsomega.2c05307","article-title":"Recent advances of DprE1 inhibitors against Mycobacterium tuberculosis: computational analysis of physicochemical and ADMET properties","volume":"7","author":"Amado","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118324_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300099","article-title":"DprE1 inhibitors: enduring aspirations for future antituberculosis drug discovery","volume":"18","author":"Yadav","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118324_bib63","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/app10020623","article-title":"Promiscuous targets for antitubercular drug discovery: the paradigm of DprE1 and MmpL3","volume":"10","author":"Degiacomi","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ejmech.2025.118324_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113207","article-title":"Easily accessed nitroquinolones exhibiting potent and selective anti-tubercular activity","volume":"213","author":"Dube","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib65","doi-asserted-by":"crossref","first-page":"11354","DOI":"10.1073\/pnas.1205735109","article-title":"Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors","volume":"109","author":"Batt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.118324_bib66","doi-asserted-by":"crossref","first-page":"13663","DOI":"10.1021\/ja106357w","article-title":"Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-\u03b2-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis","volume":"132","author":"Trefzer","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118324_bib67","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.1171583","article-title":"Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis","volume":"324","author":"Makarov","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118324_bib68","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1128\/AAC.00778-15","article-title":"The 8-pyrrole-benzothiazinones are noncovalent inhibitors of DprE1 from Mycobacterium tuberculosis","volume":"59","author":"Makarov","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1087057116671509","article-title":"A perspective on the kinetics of covalent and irreversible inhibition","volume":"22","author":"Strelow","year":"2017","journal-title":"SLAS Discov"},{"key":"10.1016\/j.ejmech.2025.118324_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004395","article-title":"Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis","volume":"4","author":"Neres","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.118324_bib71","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1016\/j.bmc.2015.11.017","article-title":"Discovery of benzothiazoles as antimycobacterial agents: synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-\u03b2-D-ribose 2'-oxidase","volume":"23","author":"Landge","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib72","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tube.2010.09.001","article-title":"Leads for antitubercular compounds from kinase inhibitor library screens","volume":"90","author":"Magnet","year":"2010","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2025.118324_bib73","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1021\/cb300151m","article-title":"Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening","volume":"7","author":"Stanley","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118324_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02020-19","article-title":"OPC-167832, a novel carbostyril derivative with potent antituberculosis activity as a DprE1 inhibitor","volume":"64","author":"Hariguchi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00583-21","article-title":"Comparative analysis of pharmacodynamics in the C3HeB\/FeJ mouse tuberculosis model for DprE1 inhibitors TBA-7371, PBTZ169, and OPC-167832","volume":"65","author":"Robertson","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib76","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/381972","article-title":"Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections","volume":"38","author":"Pankey","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118324_bib77","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/cid\/cix1127","article-title":"Busting the myth of \"static vs cidal\": a systemic literature review","volume":"66","author":"Wald-Dickler","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118324_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkae380","article-title":"Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice","volume":"80","author":"Ishak","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.118324_bib79","series-title":"Pyridine derivatives and their use as anticoccidial agents Patent US","author":"Morisawa","year":"1977"},{"key":"10.1016\/j.ejmech.2025.118324_bib80","article-title":"Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto","author":"Heemstra","year":"2016","journal-title":"Patent WO 2016\/168059 A1"},{"key":"10.1016\/j.ejmech.2025.118324_bib81","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1021\/acsmedchemlett.2c00401","article-title":"Synthesis and biological evaluation of aurachin D analogues as inhibitors of Mycobacterium tuberculosis cytochrome bd oxidase","volume":"13","author":"Lawer","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118324_bib82","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1021\/acsmedchemlett.1c00683","article-title":"Stereochemical effects on the antimicrobial properties of tetrasubstituted 2,5-diketopiperazines","volume":"13","author":"Grant","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118324_bib83","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae086","article-title":"Antibiotic resistance in Mycobacterium tuberculosis alters tolerance to cell wall-targeting inhibitors","volume":"6","author":"Jowsey","year":"2024","journal-title":"JAC Antimicrob. Resist."},{"key":"10.1016\/j.ejmech.2025.118324_bib84","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.chembiol.2023.12.002","article-title":"A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis","volume":"31","author":"Adolph","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118324_bib85","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s41467-023-37184-7","article-title":"The evolution of antibiotic resistance is associated with collateral drug phenotypes in Mycobacterium tuberculosis","volume":"14","author":"Waller","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118324_bib86","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1021\/acs.jmedchem.5b01699","article-title":"Repositioning antitubercular 6-nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for neglected tropical diseases: structure\u2013activity studies on a preclinical candidate for visceral leishmaniasis","volume":"59","author":"Thompson","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib87","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1038\/s41467-024-48269-2","article-title":"Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapy","volume":"15","author":"Mistretta","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118324_bib88","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4155\/fmc-2023-0096","article-title":"Novel pyrimidine-1,3,4-oxadiazole hybrids and their precursors as potential antimycobacterial agents","volume":"15","author":"Pfl\u00e9gr","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118324_bib89","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1194\/jlr.M400047-JLR200","article-title":"Identification of a novel class of \u03c9,E,E-farnesyl diphosphate synthase from Mycobacterium tuberculosis","volume":"45","author":"Dhiman","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejmech.2025.118324_bib90","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nchembio.794","article-title":"Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane","volume":"8","author":"Grzegorzewicz","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118324_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115976","article-title":"Benzothiozinone derivatives with anti-tubercular activity - further side chain investigation","volume":"264","author":"Wu","year":"2024","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342501089X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342501089X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:59:59Z","timestamp":1780909199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342501089X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":91,"alternative-id":["S022352342501089X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118324","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing the antituberculosis activity of nitropicolinic acids and amides","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118324"}}